---
title: "The worst time to solve a problem is after you've already solved it"
author: Blake Green
source_url: https://blake.ist/posts/the-worst-time-to-solve-a-problem-is-after-youve-already-solved-it
publish_date: '2025-10-23'
scraped_date: '2026-01-19'
---

The pharmaceutical marketing industry has optimized the wrong bottleneck for two decades. Rather than execution speed being the core limitation, the actual constraint is imagination and creative variance.

## The Hidden Problem

"Pharma marketing isn't slow because review takes six weeks. It's unimaginative because you only get three shots per quarter." When resources are scarce, teams default to safe choices rather than experimental approaches.

## Execution vs. Innovation

As AI automation makes content generation nearly free, the real bottleneck shifts from "Can we build this?" to "What's worth building?" Digital photography didn't speed up film development; it enabled trying 200 shots instead of 10.

## Cultural Friction

The challenge isn't technical. It's convincing stakeholders to trust autonomous systems for compliance validation rather than manually reviewing every asset.

## Career Implications

Roles built around navigating regulatory processes become less valuable. Taste, intuition, and strategic thinking become the premium skills.

## The Uncomfortable Truth

Many pharma marketing outputs aren't limited by complianceâ€”they're limited by mediocrity. Automation simply exposes which teams possess genuine creative capability versus those relying on process constraints as excuses.
